![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Bioform Medical (MM) | NASDAQ:BFRM | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 5.44 | 0 | 01:00:00 |
Bull & Lifshitz, LLP announces an investigation into possible breaches of fiduciary duty and violations of state law in connection with the proposed sale of BioForm Medical, Inc. (Nasdaq:BFRM - News) (referred to as "Bioform" or the “Company”) to Merz Pharma Group.
Bull & Lifshitz, LLP's investigation is focused on whether the proposed deal provides adequate value to the Company’s shareholders.
If you are a holder of BioForm stock and want to discuss your legal rights, you may e-mail or call Bull & Lifshitz, LLP who will, without obligation or cost to you, attempt to answer your questions.
You may contact Peter D. Bull, Esq. or Joshua M. Lifshitz, Esq. at 18 East 41st Street, New York, NY, 10017, by telephone at: (866) 313-6222 or by sending an e-mail including your contact information to: counsel@nyclasslaw.com. All e-mail correspondence should make reference to Bioform.
Bull & Lifshitz, LLP is a New York City-based law firm with significant experience representing investors in merger-related shareholder class actions, shareholder derivative actions, and securities fraud class actions. For more information about the firm, please visit our website at www.nyclasslaw.com.
1 Year Bioform Medical (MM) Chart |
1 Month Bioform Medical (MM) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions